Arcutis Biotherapeutics, Inc.: director Welgus Howard G. sold 4,728 shares

What happened

• Welgus Howard G., a director, exercised options totaling 4,094 shares and sold 4,728 shares on Oct 15, 2026. The exercises were: 822 shares at $6.52 for $5,361; 1,018 shares at $7.51 for $7,645; and 2,254 shares at $8.63 for $19,452 (total exercise cost reported $32,458). An open-market sale of 4,728 shares occurred at $26.93 for $127,325. The filing also reports disposals of derivative shares (822, 1,018 and 2,254) at $0.00 each.

Key details

• Transaction date(s) and price(s):
  • Oct 15, 2026 — exercised 822 shares at $6.52 (Acquired) = $5,361.
  • Oct 15, 2026 — exercised 1,018 shares at $7.51 (Acquired) = $7,645.
  • Oct 15, 2026 — exercised 2,254 shares at $8.63 (Acquired) = $19,452.
  • Oct 15, 2026 — sold 4,728 shares at $26.93 (Disposed) = $127,325.
  • Oct 15, 2026 — disposed derivative shares 822, 1,018 and 2,254 at $0.00 (reported as derivative disposals).
• Shares owned after the transaction: not reported in this filing excerpt.
• Footnotes:
  • The trades were effected pursuant to a 10b5-1 trading plan adopted Mar 13, 2026, with a plan end date of Jun 15, 2027 (F1).
  • The option is fully vested (F2).
• Filing timeliness: no late filing is indicated in the provided summary.

Why it may matter

• The filing shows option exercises and same-day open-market sales; the filing also reports derivative disposals at $0.00 on the same date.
• This is a director (not a 10% owner or officer designation in the filing text provided).
• This filing does not show why the insider traded or why the company acted.